Among the 20 genes which have been investigated as prognostic biomarkers for AML is GABRG3, the mutated genes examined, seem to participate in several cancer pathways, including the PI3K/AKT and RAS/MAPK pathways [40]. This evidence concerns the gene GABRG3 and cancer.